The following side effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
Rare (can affect less than 1 in 100 people)
Rare (can affect less than 1 in 1,000 people)
-Delayed growth in children and adolescents.
-Decreased bone mineral density.
-Glaucoma.
-Weight gain.
-Round face (moon-shaped) (Cushing's syndrome).
Your doctor will regularly monitor any of these side effects and ensure that you are taking the lowest dose of Inaladuo to control your asthma.
Unknown frequency, but may also occur:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSpanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use Inaladuo after the expiration date that appears on the label and on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Do not dispose of medications through drains or trash. Deposit containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Inaladuo
Appearance of the product and contents of the packaging
Inaladuo Accuhaler contains an alveoli strip. The alveoli protect the inhalation powder from atmospheric effects.
Each dose is pre-dispensed.
The devices are found in packaging of 1 Accuhaler x 60 inhalations.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
GlaxoSmithKline, S.A., P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel: +34 900 202 700
Responsible manufacturer:
Glaxo Wellcome Production
Zone Industrielle nº 2, 23 Rue Lavoisier, La Madeleine, 27000 Evreux, France.
Tel: + 33 2 3223 5500
Fax: +33 2 3223 5558
or
Aspen Bad Oldesloe GmbH
Industriestrasse 32-36, 23843 Bad Oldesloe, Germany.
This leaflet has been reviewed in July 2020.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.